Dr. Gooptu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Ave
Boston, MA 02215Phone+1 617-632-6000
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Hematology and Medical Oncology, 2013 - 2016
Albert Einstein Healthcare NetworkResidency, Internal Medicine, 2009 - 2012
Medical College and Hospital KolkataClass of 2007
Certifications & Licensure
ME State Medical License Current
MA State Medical License 2016 - 2026
RI State Medical License 2022 - 2026
PA State Medical License 2009 - 2016
MO State Medical License 2012 - 2012
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013
Publications & Presentations
PubMed
- Improved Patient-Reported Outcomes With Post-Transplant Cyclophosphamide: A Quality-of-Life Evaluation and 2-Year Outcomes of BMT CTN 1703.Shernan G Holtan, Javier Bolaños-Meade, Monzr M Al Malki, Juan Wu, Carrie L Kitko
Journal of Clinical Oncology. 2025-03-10 - Graft-versus-host disease prophylaxis shapes T cell biology and immune reconstitution after hematopoietic cell transplant.Steven J Siegel, Susan DeWolf, Joseph Schmalz, Wael Saber, Jiayi Dong
Medrxiv. 2025-02-26 - Reply to: Disparities in Allograft Access in the Era of Post-Transplant Cyclophosphamide-Based Mismatched Unrelated Donor Transplantation.Brian C Shaffer, Mahasweta Gooptu, Todd DeFor, Stephen R Spellman, Heather E Stefanski
Journal of Clinical Oncology. 2025-02-01
Abstracts/Posters
- Graft Failure after Haploidentical Hematopoietic Stem Cell TransplantationMahasweta Gooptu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Improved Outcomes with Cyclophosphamide/Total Body Irradiation 14 Gy Compared to Cyclophosphamide/Total Body Irradiation 12 Gy in Patients with Acute Lymphoblastic Leu...Mahasweta Gooptu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Anti-CD6 Monoclonal Antibody Itolizumab Efficiently Inhibits T Cell Proliferation after in Vitro TCR Stimulation in the Setting of Acute Graft Versus Host DiseaseMahasweta Gooptu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Press Mentions
Importance of Donor HLA Matching Confirmed, but Research Highlights Health DisparityAugust 31st, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
